Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of Exercise Intensity in Obese Children and Adolescents

19. februar 2018 oppdatert av: Norwegian University of Science and Technology

A Multi-centre Randomized Controlled Trial Examining the Effects of High Intensity Interval Training on Cardio-metabolic Outcomes in Obese Children and Adolescents

The prevalence of paediatric obesity has increased over the last two decades and with it, an increased diagnosis of lifestyle-related diseases in children and adolescents. High intensity interval training has recently been explored as an alternate to traditional aerobic exercise in adults with chronic disease and has potential to induce rapid reversal of subclinical disease markers in obese children and adolescents.

High intensity interval training has recently been explored as an alternate to traditional aerobic exercise in adults with chronic disease and has potential to induce rapid reversal of subclinical disease markers in obese children and adolescents.

Goal: The primary aim of this randomised controlled trial is to evaluate the effectiveness of a high intensity interval training intervention on myocardial function, vascular function and visceral adipose tissue in obese children and adolescents at baseline, three and twelve months.

Method: Multi-centre randomised controlled trial of 100 obese children and adolescents in the cities of Trondheim (Norway) and Brisbane (Australia). Participants will be randomised to (1) high intensity interval training, (2) moderate intensity continuous training or (3) nutrition advise. Participants will partake in supervised exercise training and/or nutrition consultations for 3 months. Measurements for all study endpoints will occur at baseline, 3 months (post intervention) and 12 months (follow up).

Scientific Significance : This randomised controlled trial will general substantial information regarding the effects of exercise intensity on paediatric obesity, specifically the cardio-metabolic health of this at-risk population. It is expected that communication of results will allow for more robust and realistic guidelines regarding exercise prescription in this population to be formed while outlining the benefits of high intensity interval training on subclinical markers of disease.

Studieoversikt

Detaljert beskrivelse

Worldwide, childhood overweight and obesity rates are approximately 10%, this high incidence attributed to a physically inactive lifestyle and inappropriate nutrition. Early cohort studies illustrated that fifty per cent of obese children became obese adults and consequently had an higher risk for metabolic syndrome than obese adults who were not obese as children. Both female and male overweight children and adolescents had a 30% increase in all cause mortality. The increases in risk of death were independent of adult body mass index.

Systematic reviews suggest that lifestyle and exercise interventions in obese children and adolescents can lead to improvements in anthropometric and cardio-metabolic outcomes, but these are not inclusive of several important outcomes such as myocardial and vascular function or visceral adipose tissue.

Studietype

Intervensjonell

Registrering (Faktiske)

100

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Brisbane, Australia
        • University of Queensland
      • Trondheim, Norge
        • St Olavs Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

7 år til 16 år (Barn)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

- Obese (BMI ≥ 95th percentile - age and sex specific criteria)

Exclusion Criteria:

  • Elevated blood pressure (≥ 95th percentile for systolic or diastolic values)
  • Congenital heart disease
  • Coronary artery disease
  • Family history of hypertropic obstructive cardiomyopathy
  • Any abnormality during rest or stress echocardiography which indicates it would be unsafe to participate
  • Self reported kidney failure
  • Any major organ transplant
  • Considerable pulmonary disease including severe or poorly controlled asthma
  • Smoking
  • Diabetes
  • Epilepsy or a history of seizures
  • Orthopaedic or neurological limitations to exercise
  • Diagnosed attention deficit hypersensitivity disorder
  • Steroid medications
  • Participation in another research study

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: High intensity interval training
10-minute warm up at 60-70% of maximal heart rate (HRmax). Then walking, running or cycling at 85-95% of maximal heart rate at intervals of 4 x 4 minutes, with 3 minute active breaks (50-70% of HRmax) between intervals. A 5-minute cool down period.
Twelve weeks of 2-3 supervised training sessions each week.
Andre navn:
  • HIIT
healthy food choices, portion sizes and regular mealtimes
Eksperimentell: Moderate intensity continuous training
walking, running or cycling continuously at 60-70% HRmax for 44 minutes.
healthy food choices, portion sizes and regular mealtimes
Twelve weeks of 2-3 supervised training sessions each week.
Andre navn:
  • MICT
Aktiv komparator: nutritional advice
10 individual nutrition consultations with an accredited dietitian over the 12 month period. Content of consultations will include healthy food choices, portion sizes and regular mealtimes.
healthy food choices, portion sizes and regular mealtimes
Ingen inngripen: non-obese children
100 healthy non-obese children aged 7-16 (controls)

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Peak systolic tissue velocity
Tidsramme: 12 weeks
systolic tissue Doppler velocity assessed during resting and stress echocardiography
12 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Subcutaneous and total abdominal adipose tissue
Tidsramme: 12 weeks, 12 months
Assessed using MRI
12 weeks, 12 months
Cardiorespiratory fitness (VO2peak)
Tidsramme: 12 weeks, 12 months
Assessed using a maximal treadmill test
12 weeks, 12 months
Body composition
Tidsramme: 12 weeks, 12 months
Assessed using DXA (UQ), BodPod (NTNU)
12 weeks, 12 months
Blood biochemistry
Tidsramme: 12 weeks, 12 months
Analysed for lipids, glucose, insulin, inflammatory makers, satiety hormones, oxidative stress
12 weeks, 12 months
Physical activity
Tidsramme: 12 weeks, 12 months
Assessed through 7 day accelerometry
12 weeks, 12 months
Dietary analysis
Tidsramme: 12 weeks, 12 months
Assessed through a three-day food record
12 weeks, 12 months
Myocardial structure and cardiac adipose tissue (UQ)
Tidsramme: 12 weeks
Assessed through cardiac MRI; participants > 12 years only
12 weeks
Arterial stiffness
Tidsramme: 12 weeks, 12 months
Assessed through pulse wave velocity and pulse wave analysis
12 weeks, 12 months
Autonomic function
Tidsramme: 12 weeks, 12 months
Assessed through heart rate variability and heart rate recovery
12 weeks, 12 months
Quality of life
Tidsramme: 12 weeks, 12 months
Assessed through the Paediatric Quality of Life Inventory
12 weeks, 12 months
Visceral adipose tissue
Tidsramme: 12 weeks, 12 months
assessed by magnetic resonance imaging (MRI)
12 weeks, 12 months
Vascular function
Tidsramme: 12 weeks, 12 months
Assessed through flow mediated dilation procedure
12 weeks, 12 months
Peak systolic tissue velocity
Tidsramme: 12 months
systolic tissue Doppler velocity assessed during resting and stress echocardiography
12 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. november 2013

Primær fullføring (Faktiske)

31. mars 2017

Studiet fullført (Faktiske)

31. mars 2017

Datoer for studieregistrering

Først innsendt

18. november 2013

Først innsendt som oppfylte QC-kriteriene

18. november 2013

Først lagt ut (Anslag)

25. november 2013

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

20. februar 2018

Siste oppdatering sendt inn som oppfylte QC-kriteriene

19. februar 2018

Sist bekreftet

1. februar 2018

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere